Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%

NCT02656329 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT02656329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02656329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Lead sponsor
GE Healthcare
Phase
Phase 3
Overall status
Terminated
Start date
December 30, 2015
Completion date
May 4, 2018
Enrollment
395 (actual)
Sites
94

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure